[ESPR] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
06-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -26.32%
YoY- -189.55%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 24,329 18,836 7,978 1,840 145,419 0 0 -
PBT -61,719 -56,731 -90,935 -78,249 87,379 -46,130 -40,541 7.25%
Tax 27,501 13,742 8,139 4,539 0 0 482 96.14%
NP -89,220 -70,473 -90,935 -78,249 87,379 -46,130 -40,541 14.04%
Tax Rate - - - - 0.00% - - -
Total Cost 113,549 89,309 98,913 80,089 58,040 46,130 40,541 18.71%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin -366.72 -374.14 -1,139.82 -4,252.66 60.09 0.00 0.00 -
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -1.14 -1.16 -3.50 -2.84 3.26 -1.73 -1.80 -7.32%
EPS Diluted -1.14 -1.16 -3.50 -2.84 3.07 -1.73 -1.80 -7.32%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.